Abstract: Methods and compositions for a probiotic strain selected by targeted in vivo (in the human gut) enrichment to aid with healthy lactose digestion are provided. The probiotic strain selected may beneficially include Bifidobacterium adolescentis strain IVS-1 for reducing and/or preventing symptoms of lactose intolerance in a subject in need thereof.

Abstract: Lactobacillus reuteri strain having NCIMB accession number 42835 is from a novel phylogenetic clade and has unique immune-stimulatory properties and enhanced ecological performance in the human gut. A substrate for the strain, such as raffinose, may be administered at the same time as or separately from the strain.

Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.

Abstract: A metering device for controlled receiving and/or dispensing of one or more media, includes one or more pump unit(s) and one or more control units having at least one signal input device configured to record one or more user input(s). The at least one signal input device includes one or more sensor(s) configured to detect the user input(s) and to convert the detected user input(s) into one or more measured value(s). One or more evaluation unit(s) are configured to control the pump unit(s) as a function of the measured value(s). The user input(s) is/are an action of force of a pressure change (?p) effected by a user. In addition, a method for operating the metering device is provided.

Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.

Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.

Abstract: This disclosure describes novel probiotics, and also describes novel methods by which such probiotics can be obtained.

Abstract: The present invention provides methods for identifying genes and proteins that may regulate angiogenesis. The genes identified may be used as markers for the disease onset and progression and to measure efficacy of a therapeutic. The present invention also provides methods to screen agents that are capable of regulating angiogenesis. The present invention also provides methods of identifying therapeutic compounds that may treat various disorders by regulating the expression and activity of genes and proteins identified.